EFFECT OF DAPAGLIFLOZIN ON BODY COMPOSITION IN PATIENTS WITH TYPE 1 DIABETES
Por:
Sierra, N, Leon, J, Del Valle, C, Exposito, J, Villena, B, Morant, C, Izquierdo, E and Arino, C
Publicada:
1 jun 2021
Resumen:
Filiaciones:
:
Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Endocrinol, Valencia, Spain
:
Doctor Peset Univ Hosp, Endocrinol & Nutr, Valencia, Spain
:
Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Endocrinol, Valencia, Spain
:
Doctor Peset Univ Hosp, Endocrinol & Nutr, Valencia, Spain
:
Doctor Peset Univ Hosp, Endocrinol & Nutr, Valencia, Spain
:
Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Endocrinol, Valencia, Spain
:
Univ Valencia, Dept Med, Valencia, Spain
Hosp Univ Doctor Peset, Endocrinol, Valencia, Spain
:
Doctor Peset Univ Hosp, Endocrinol & Nutr, Valencia, Spain
Univ Valencia, Dept Med, Valencia, Spain
|